Molecular Mechanism and Development of Therapeutic Strategies Targeting MYCN-induced Calcium Signaling in Advanced Neuroblastoma |
University of Hawaii at Hilo / Ingo Koomoa-Lange, PhD |
Young Investigator Grants |
2014 |
Hawaii |
Phase I Trial of Indoximod in Combination with Temozolomide-based Therapy for Children with Progressive Primary Brain Tumors |
Georgia Health Sciences University Research Institute, Inc. / Theodore Johnson, M.D., Ph.D. |
Bio-Therapeutic Impact Award |
2014 |
Georgia |
Development of AAV Vectors for Efficient Targeting and Elimination of Osteosarcoma Tumor-Initiating Cells |
University of Florida / Steven Ghivizzani, Ph.D. |
Innovation Grants |
2014 |
Florida |
Neurocognitive Assessments within COG: An Intensive, Integrated Model for Successfully Evaluating Children with High-Risk ALL |
Children’s Research Institute / Kristina Hardy, PhD |
Psychosocial Grants |
2014 |
District of Columbia |
Targeting the Six1/Eya Transcriptional Complex to Inhibit Pediatric Sarcomas |
University of Colorado Denver / Heide Ford, Ph.D. |
Innovation Grants |
2014 |
Colorado |
Autophagy and mTOR Inhibition in Pediatric Gliomas with BRAF Mutations |
University of Colorado Denver / Jean Mulcahy Levy, MD |
Young Investigator Grants |
2014 |
Colorado |
Exploiting Epigenetic Dependencies of Notch1 for Clinical Benefit |
University of Colorado Denver / Patricia Ernst, Ph.D. |
Innovation Grants |
2014 |
Colorado |
Targeting the Accomplices of MYC in MYC-driven Medulloblastoma |
Sanford-Burnham Medical Research Institute / Robert Wechsler-Reya, Ph.D. |
Innovation Grants |
2014 |
California |
Investigating the Role of Genetic and Epigenetic Variation in Risk of Childhood Acute Lymphoblastic Leukemia in Down Syndrome |
University of California San Francisco / Adam de Smith, Ph.D. |
'A' Award Grants |
2014 |
California |
Perinatal Hormonal Biomarkers and Risk of Testicular Germ Cell Tumors |
University of California Berkeley / Catherine Metayer, MD, PhD |
Epidemiology Grants |
2014 |
California |